Covid Vaccine: To eliminate the deadly corona virus in the country, the central government has intensified the vaccination campaign. A total of four vaccines have now been approved in the country. Covishield and Covaccine are already there. Sputnik and now Mumbai-based pharmaceutical company Cipla have been approved by the Drug Controller General of India (DCGI) to import Moderna’s vaccine.
Moderna’s vaccine is the fourth vaccine to be available in India
Moderna’s vaccine will be the fourth corona vaccine to be available in India after Covishield, Covaccine and Sputnik. NITI Aayog Member (Health) Dr VK Paul has said, “An application was received through Moderna’s Indian partner Cipla, following which Moderna’s vaccine has been permitted for limited emergency use by the drug regulator.”
“We are also continuing our efforts to invite other internationally developed vaccines, notably Pfizer and Johnson & Johnson,” Paul said. We are also looking at increasing the production of the vaccine being manufactured in our country.
Who got the approval when-
- Coveshield of Serum Institute of India in January 2021
- Bharat Biotech’s Vaccine Covaccine also in January 2021
- Sputnik was approved for emergency use in April 2021.
Government took steps to speed up vaccination
It is noteworthy that in order to accelerate vaccination, DCGI on June 1 decided to exempt the testing of their consignment in CDL for those vaccines made abroad, which have been approved by international drug regulators like USFDA, UK’s MHRA or World Health Organization. Approval has been received.